.jpg) |
Rice University bioscientists James Chappell (left) and Joff Silberg aim to create “genetically encoded antibiotics,” strands of RNA that bacteria will readily copy and share. The RNA will selectively kill disease-causing bacteria thanks to a triggering mechanism that will be activated by “virulence genes” or other biomarkers found only in bacterial pathogens. Photo Credit: Jeff Fitlow/Rice University |
Synthetic biologists at Rice University are embarking on a three-year project to create “genetically encoded antibiotics,” strands of RNA that bacteria will readily copy and share that will selectively kill only disease-causing, pathogenic bacteria.
“Most bacteria pose no danger to human health,” said James Chappell, an assistant professor of biosciences and bioengineering at Rice. “The question for us as synthetic biologists is, ‘Can we create genetic programs that move through microbial communities and precisely remove only the bad actors from those communities?’”
Thanks to a $1.5 million grant from the Kleberg Foundation, Chappell’s lab and the lab of Rice bioscientist and bioengineer Jonathan “Joff” Silberg are getting a chance to test their idea of combating antibiotic resistance by enlisting the aid of bacteria that either benefit humans or pose no threat to them.
In prototype tests, they showed they could design RNA programs that were highly targeted and potent, killing 99.99% of “bad actor” pathogens within a matter of hours. In the three-year project, they also plan to partner with Dr. Pablo Okhuysen from the University of Texas MD Anderson Cancer Center to design RNA antibiotics that are effective against diarrhea-causing E. coli, as well as RNA drugs that selectively kill the opportunistic Lactobacillus iners, a pathogen that has been associated with cervical cancer radiation therapy resistance.